Dew, thanks so much for the reply; I appreciate your insight. You make a good point about the commercial rights for ABT-493. Also, thanks for pointing me over to the clinicaltrials.gov website. I had forgotten that they included estimated completion times on that site. Overall, it seems like we still have a decent number of upcoming catalysts and milestones for ENTA in 2014 to look forward to.
I'm excited for ENTA's future. Hope things continue trending in the right direction.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.